ORE LEG Drug Reimbursement Bill


On Mar. 7, ORE LEG passed bill on prescription drug reimbursement.


  • ORE LEG passed bill HB 4012 regarding the reimbursement of clinician-administered prescription drugs, amending ORE INS 750.055 and ORE INS 750.333 on insurance.
  • Bill Provisions
  • Covers health benefit plan issuers, health care service contractors or multiple employer welfare arrangements re reimbursement of clinician-administered prescription drugs.
  • Prohibits health insurance issuers from requiring that drugs that are administered by health care providers be dispensed at a certain pharmacy under certain circumstances.
  • Legislative History
  • On Feb. 5, 2024, bill introduced in House; on Feb. 22, 2024, bill was passed in House.
  • On Feb. 22, 2024, bill delivered to Senate; on Mar. 5, 2024, bill was passed in Senate.
  • On Mar. 6, 2024, bill signed by House Speaker; on Mar. 7, 2024, by Senate President.
  • Effectiveness
  • Act of the Legislature takes effect on Jan. 1 of the year after its passage.
  • Mar. 27, 2024 ORE LEG Governor Approval
  • On Mar. 28, 2024, ORE LEG reported governor signed HB 4012, bill assigned Ch. 24.

Regulators ORE LEG
Entity Types Ins
Reference Ch 24, 3/28/2024; Bill, HB4012, 3/7/2024; Citation: *ORE INS* 750.055, 750.333;
Functions Claims/Accelerated Benefits; Compliance; Financial; Legal; Product Administration
Countries United States of America
Category
State
Products Insurance; Insurance-Health
Regions Am
Rule Type Final
Rule Date 3/7/2024
Effective Date 1/1/2025
Rule Id 203895
Linked to N/A
Reg. Last Update 3/28/2024
Report Section US Insurance

Last substantive update on 04/02/2024